{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:01:49Z","timestamp":1793012509062,"version":"4.5.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Placebo effects have been linked to a range of clinical symptoms. Traditionally, it was believed that deception was necessary for placebos to work. However, emerging research shows that openly administered placebos can benefit patients with various medical conditions. This study aimed to analyze the effects of Open-Label Placebo (OLP) on physical function and pain in individuals with chronic musculoskeletal pain. We conducted, in August 2024, a systematic literature search in PubMed, Web of Science, PsycINFO, and EMBASE for RCTs comparing OLP with any other intervention or no treatment. The level of evidence was assessed with GRADE. The effects on physical function tests were analyzed descriptively, while patient-reported outcome measures (PROMs) on physical functioning and pain were synthesized using random-effects meta-analyses. Study quality was assessed using the revised Cochrane risk of bias tool, RoB2. From 1775 articles, seven RCTs with a total of 703 participants were included\u2014five on back pain and two on knee pain. All seven studies had a high risk of bias for PROMs due to awareness of the intervention. Among the four studies that reported objective outcomes, two had a low risk of bias and two had some concerns. All studies included a follow-up between 3 and 12 weeks, except for one study that had a 3-year follow-up. With moderate evidence, we found that OLP as a stand-alone or add-on treatment had no effect on physical function tests, but concerning PROMs, there was low evidence for very small to moderate effects on self-reported physical function (SMD\u2009=\u20090.40, 95% CI 0.19\u20130.60) and small to moderate effects on pain intensity (SMD\u2009=\u20090.46, 95% CI 0.28\u20130.63) compared to treatment as usual or no treatment. These results suggest that OLP may enhance PROMs in chronic musculoskeletal pain patients, but one should keep in mind that the clinical value of OLP is not yet established. This study received no specific funding.<\/jats:p>\n                  <jats:p>Registered in PROSPERO: CRD42023487578.<\/jats:p>","DOI":"10.1038\/s41598-025-09415-y","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T23:08:12Z","timestamp":1751670492000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A systematic review and meta analysis of open label placebo effects in chronic musculoskeletal pain"],"prefix":"10.1038","volume":"15","author":[{"given":"Fredrik","family":"Borg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Gedin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Franz\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelmus Johannes Andreas","family":"Grooten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,5]]},"reference":[{"key":"9415_CR1","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/S0140-6736(16)31678-6","volume":"388","author":"T Vos","year":"2016","unstructured":"Vos, T. et al. Global, regional, and National incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990\u20132015: a systematic analysis for the global burden of disease study 2015. Lancet. 388, 1545\u20131602 (2016).","journal-title":"Lancet"},{"key":"9415_CR2","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/S0140-6736(16)30970-9","volume":"389","author":"C Maher","year":"2017","unstructured":"Maher, C., Underwood, M. & Buchbinder, R. Non-specific low back pain. Lancet. 389, 736\u2013747 (2017).","journal-title":"Lancet"},{"key":"9415_CR3","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1002\/art.34347","volume":"64","author":"D Hoy","year":"2012","unstructured":"Hoy, D. et al. A systematic review of the global prevalence of low back pain. Arthritis Rheum. 64, 2028\u20132037 (2012).","journal-title":"Arthritis Rheum."},{"key":"9415_CR4","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1016\/S0140-6736(18)30480-X","volume":"391","author":"J Hartvigsen","year":"2018","unstructured":"Hartvigsen, J. et al. What low back pain is and why we need to pay attention. Lancet Lond. Engl. 391, 2356\u20132367 (2018).","journal-title":"Lancet Lond. Engl."},{"key":"9415_CR5","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.pnpbp.2019.04.006","volume":"93","author":"AF Domenichiello","year":"2019","unstructured":"Domenichiello, A. F. & Ramsden, C. E. The silent epidemic of chronic pain in older adults. Prog. Neuropsychopharmacol. Biol. Psychiatry. 93, 284\u2013290 (2019).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"9415_CR6","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/rheumatology\/ken021","volume":"47","author":"L Scascighini","year":"2008","unstructured":"Scascighini, L., Toma, V., Dober-Spielmann, S. & Sprott, H. Multidisciplinary treatment for chronic pain: a systematic review of interventions and outcomes. Rheumatology. 47, 670\u2013678 (2008).","journal-title":"Rheumatology"},{"key":"9415_CR7","unstructured":"Gauthier, K., Dulong, C. & Arg\u00e1ez, C. Multidisciplinary Treatment Programs for Patients with Chronic Non-Malignant Pain: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines\u2014An Update (Canadian Agency for Drugs and Technologies in Health, 2019)."},{"key":"9415_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13012-016-0533-0","volume":"12","author":"DV Ernstzen","year":"2017","unstructured":"Ernstzen, D. V., Louw, Q. A. & Hillier, S. L. Clinical practice guidelines for the management of chronic musculoskeletal pain in primary healthcare: a systematic review. Implement. Sci. 12, 1 (2017).","journal-title":"Implement. Sci."},{"key":"9415_CR9","unstructured":"Abuse, N. I. on D. Drug Overdose Deaths: Facts and Figures | National Institute on Drug Abuse (NIDA).  https:\/\/nida.nih.gov\/research-topics\/trends-statistics\/overdose-death-rates (2024)."},{"key":"9415_CR10","doi-asserted-by":"publisher","unstructured":"Rubinstein, S. M. et al. Benefits and harms of spinal manipulative therapy for the treatment of chronic low back pain: systematic review and meta-analysis of randomised controlled trials. BMJ. l689. https:\/\/doi.org\/10.1136\/bmj.l689 (2019).","DOI":"10.1136\/bmj.l689"},{"key":"9415_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.physio.2021.03.006","volume":"112","author":"A De Zoete","year":"2021","unstructured":"De Zoete, A. et al. The effect of spinal manipulative therapy on pain relief and function in patients with chronic low back pain: an individual participant data meta-analysis. Physiotherapy. 112, 121\u2013134 (2021).","journal-title":"Physiotherapy"},{"key":"9415_CR12","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1186\/s12891-022-05722-x","volume":"23","author":"WJA Grooten","year":"2022","unstructured":"Grooten, W. J. A. et al. Summarizing the effects of different exercise types in chronic low back pain\u2014a systematic review of systematic reviews. BMC Musculoskelet. Disord. 23, 801 (2022).","journal-title":"BMC Musculoskelet. Disord"},{"key":"9415_CR13","doi-asserted-by":"publisher","first-page":"e15591","DOI":"10.1371\/journal.pone.0015591","volume":"5","author":"TJ Kaptchuk","year":"2010","unstructured":"Kaptchuk, T. J. et al. Placebos without deception: A randomized controlled trial in irritable bowel syndrome. PLoS One. 5, e15591 (2010).","journal-title":"PLoS ONE"},{"key":"9415_CR14","doi-asserted-by":"publisher","unstructured":"Kaptchuk, T. J. & Miller, F. G. Open label placebo: can honestly prescribed placebos evoke meaningful therapeutic benefits? BMJ. k3889 https:\/\/doi.org\/10.1136\/bmj.k3889 (2018).","DOI":"10.1136\/bmj.k3889"},{"key":"9415_CR15","unstructured":"Microcrystalline Cellulose. What is it and where is it used? Drugs.com https:\/\/www.drugs.com\/inactive\/microcrystalline-cellulose-48.html."},{"key":"9415_CR16","doi-asserted-by":"publisher","unstructured":"KaptchukT. J., HemondC. C. & MillerF. G. Placebos in chronic pain: evidence, theory, ethics, and use in clinical practice. BMJ. m1668. https:\/\/doi.org\/10.1136\/bmj.m1668 (2020).","DOI":"10.1136\/bmj.m1668"},{"key":"9415_CR17","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/bioe.12245","volume":"30","author":"C Blease","year":"2016","unstructured":"Blease, C., Colloca, L. & Kaptchuk, T. J. Are open-label placebos ethical?? Informed consent and ethical? equivocations. Bioethics. 30, 407\u2013414 (2016).","journal-title":"Bioethics"},{"key":"9415_CR18","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13063-017-1964-x","volume":"18","author":"S Ballou","year":"2017","unstructured":"Ballou, S. et al. Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial. Trials. 18, 234 (2017).","journal-title":"Trials"},{"key":"9415_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/bmjebm-2019-111209","volume":"25","author":"CR Blease","year":"2020","unstructured":"Blease, C. R., Bernstein, M. H. & Locher, C. Open-label placebo clinical trials: is it the rationale, the interaction or the pill? BMJ Evid. -Based Med. 25, 159\u2013165 (2020).","journal-title":"BMJ Evid. -Based Med."},{"key":"9415_CR20","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1353\/pbm.2018.0045","volume":"61","author":"TJ Kaptchuk","year":"2018","unstructured":"Kaptchuk, T. J. Open-label placebo: Reflections on a research agenda. Perspect. Biol. Med. 61, 311\u2013334 (2018).","journal-title":"Perspect. Biol. Med."},{"key":"9415_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/j.pain.0000000000001367","volume":"160","author":"G Ongaro","year":"2019","unstructured":"Ongaro, G. & Kaptchuk, T. J. Symptom perception, placebo effects, and the bayesian brain. Pain. 160, 1\u20134 (2019).","journal-title":"Pain"},{"key":"9415_CR22","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1097\/j.pain.0000000000000700","volume":"157","author":"C Carvalho","year":"2016","unstructured":"Carvalho, C. et al. Open-label placebo treatment in chronic low back pain: a randomized controlled trial. Pain. 157, 2766\u20132772 (2016).","journal-title":"Pain"},{"key":"9415_CR23","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1365-2214.2007.00797.x","volume":"34","author":"AD Sandler","year":"2008","unstructured":"Sandler, A. D. & Bodfish, J. W. Open-label use of placebos in the treatment of ADHD: a pilot study. Child. Care Health Dev. 34, 104\u2013110 (2008).","journal-title":"Child. Care Health Dev."},{"key":"9415_CR24","doi-asserted-by":"publisher","first-page":"e0192758","DOI":"10.1371\/journal.pone.0192758","volume":"13","author":"M Schaefer","year":"2018","unstructured":"Schaefer, M., Sahin, T. & Berstecher, B. Why do open-label placebos work? A randomized controlled trial of an open-label placebo induction with and without extended information about the placebo effect in allergic rhinitis. PLoS One. 13, e0192758 (2018).","journal-title":"PLoS One"},{"key":"9415_CR25","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1007\/s00520-018-4477-6","volume":"27","author":"ES Zhou","year":"2019","unstructured":"Zhou, E. S. et al. Open-label placebo reduces fatigue in cancer survivors: a randomized trial. Support Care Cancer. 27, 2179\u20132187 (2019).","journal-title":"Support Care Cancer"},{"key":"9415_CR26","doi-asserted-by":"publisher","first-page":"20090","DOI":"10.1038\/s41598-020-77255-z","volume":"10","author":"Y Pan","year":"2020","unstructured":"Pan, Y. et al. Open-label placebos for menopausal hot flushes: a randomized controlled trial. Sci. Rep. 10, 20090 (2020).","journal-title":"Sci. Rep."},{"key":"9415_CR27","doi-asserted-by":"crossref","unstructured":"Kam-Hansen, S. et al. Altered placebo and drug labeling changes the outcome of episodic migraine attacks. Sci. Transl. Med. 6, (2014).","DOI":"10.1126\/scitranslmed.3006175"},{"key":"9415_CR28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/abm\/kay011","volume":"53","author":"J El Brihi","year":"2019","unstructured":"El Brihi, J., Horne, R. & Faasse, K. Prescribing placebos: an experimental examination of the role of dose, expectancies, and adherence in open-label placebo effects. Ann. Behav. Med. Publ Soc. Behav. Med. 53, 16\u201328 (2019).","journal-title":"Ann. Behav. Med. Publ Soc. Behav. Med."},{"key":"9415_CR29","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1038\/s41467-020-17654-y","volume":"11","author":"DA Guevarra","year":"2020","unstructured":"Guevarra, D. A., Moser, J. S., Wager, T. D. & Kross, E. Placebos without deception reduce self-report and neural measures of emotional distress. Nat. Commun. 11, 3785 (2020).","journal-title":"Nat. Commun."},{"key":"9415_CR30","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s12160-016-9854-0","volume":"51","author":"JM Mundt","year":"2017","unstructured":"Mundt, J. M., Roditi, D. & Robinson, M. E. A comparison of deceptive and non-deceptive placebo analgesia: efficacy and ethical consequences. Ann. Behav. Med. Publ Soc. Behav. Med. 51, 307\u2013315 (2017).","journal-title":"Ann. Behav. Med. Publ Soc. Behav. Med."},{"key":"9415_CR31","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3389\/fpsyt.2019.00436","volume":"10","author":"SH Meeuwis","year":"2019","unstructured":"Meeuwis, S. H. et al. Effects of open- and closed-label nocebo and placebo suggestions on itch and itch expectations. Front. Psychiatry. 10, 436 (2019).","journal-title":"Front. Psychiatry"},{"key":"9415_CR32","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0167-8760(01)00188-X","volume":"43","author":"H Walach","year":"2002","unstructured":"Walach, H., Schmidt, S., Dirhold, T. & Nosch, S. The effects of a caffeine placebo and suggestion on blood pressure, heart rate, well-being and cognitive performance. Int. J. Psychophysiol. 43, 247\u2013260 (2002).","journal-title":"Int. J. Psychophysiol."},{"key":"9415_CR33","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1097\/j.pain.0000000000003017","volume":"164","author":"CMP Jones","year":"2023","unstructured":"Jones, C. M. P. et al. Time to reflect on open-label placebos and their value for clinical practice. Pain 164, 2139\u20132142 (2023).","journal-title":"Pain"},{"key":"9415_CR34","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1097\/j.pain.0000000000001803","volume":"161","author":"AB Amorim","year":"2020","unstructured":"Amorim, A. B., Machado, G. C. & Maher, C. G. Enthusiastic claims for open-label placebo pills ignore the evidence. Pain. 161, 1124 (2020).","journal-title":"Pain"},{"key":"9415_CR35","doi-asserted-by":"crossref","unstructured":"Tilburt, J. C., Emanuel, E. J., Kaptchuk, T. J., Curlin, F. A. & Miller, F. G. Prescribing \u2018placebo treatments\u2019: results of national survey of US internists and rheumatologists. BMJ. 337, a1938 (2008).","DOI":"10.1136\/bmj.a1938"},{"key":"9415_CR36","doi-asserted-by":"publisher","first-page":"e58247","DOI":"10.1371\/journal.pone.0058247","volume":"8","author":"J Howick","year":"2013","unstructured":"Howick, J. et al. Placebo use in the united kingdom: results from a National survey of primary care practitioners. PLoS One. 8, e58247 (2013).","journal-title":"PloS One"},{"key":"9415_CR37","doi-asserted-by":"crossref","unstructured":"Patient attitudes about the clinical use. of placebo: qualitative perspectives from a telephone survey | BMJ Open. https:\/\/bmjopen.bmj.com\/content\/6\/4\/e011012.","DOI":"10.1136\/bmjopen-2015-011012"},{"key":"9415_CR38","doi-asserted-by":"publisher","first-page":"k3889","DOI":"10.1136\/bmj.k3889","volume":"363","author":"TJ Kaptchuk","year":"2018","unstructured":"Kaptchuk, T. J. & Miller, F. G. Open label placebo: can honestly prescribed placebos evoke meaningful therapeutic benefits? BMJ. 363, k3889 (2018).","journal-title":"BMJ"},{"key":"9415_CR39","doi-asserted-by":"publisher","first-page":"3855","DOI":"10.1038\/s41598-021-83148-6","volume":"11","author":"M Von Wernsdorff","year":"2021","unstructured":"Von Wernsdorff, M., Loef, M., Tuschen-Caffier, B. & Schmidt, S. Effects of open-label placebos in clinical trials: a systematic review and meta-analysis. Sci. Rep. 11, 3855 (2021).","journal-title":"Sci. Rep."},{"key":"9415_CR40","doi-asserted-by":"publisher","unstructured":"Page, M. J. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. n71. https:\/\/doi.org\/10.1136\/bmj.n71 (2021).","DOI":"10.1136\/bmj.n71"},{"key":"9415_CR41","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1038\/s41598-023-30362-z","volume":"13","author":"L Spille","year":"2023","unstructured":"Spille, L., Fendel, J. C., Seuling, P. D., G\u00f6ritz, A. S. & Schmidt, S. Open-label placebos\u2014a systematic review and meta-analysis of experimental studies with non-clinical samples. Sci. Rep. 13, 3640 (2023).","journal-title":"Sci. Rep."},{"key":"9415_CR42","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/jebm.12251","volume":"10","author":"JEG Charlesworth","year":"2017","unstructured":"Charlesworth, J. E. G. et al. Effects of placebos without deception compared with no treatment: A systematic review and meta-analysis. J. Evid. -Based Med. 10, 97\u2013107 (2017).","journal-title":"J. Evid. -Based Med."},{"key":"9415_CR43","unstructured":"Svensk MeSH. https:\/\/mesh.kib.ki.se\/."},{"key":"9415_CR44","unstructured":"Zotero | Your personal research assistant. https:\/\/www.zotero.org\/."},{"key":"9415_CR45","unstructured":"Rayyan\u2014Intelligent Systematic Review - Rayyan. https:\/\/www.rayyan.ai\/ (2021)."},{"key":"9415_CR46","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/j.pain.0000000000002752","volume":"164","author":"J Kleine-Borgmann","year":"2023","unstructured":"Kleine-Borgmann, J., Dietz, T. N., Schmidt, K. & Bingel, U. No long-term effects after a 3-week open-label placebo treatment for chronic low back pain: a 3-year follow-up of a randomized controlled trial. Pain. 164, 645\u2013652 (2023).","journal-title":"Pain"},{"key":"9415_CR47","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1001\/jamapsychiatry.2021.2669","volume":"79","author":"YK Ashar","year":"2022","unstructured":"Ashar, Y. K. et al. Effect of pain reprocessing therapy vs placebo and usual care for patients with chronic back pain: A randomized clinical trial. JAMA Psychiatry. 79, 13 (2022).","journal-title":"JAMA Psychiatry"},{"key":"9415_CR48","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1136\/annrheumdis-2021-221129","volume":"81","author":"E Bandak","year":"2022","unstructured":"Bandak, E. et al. Exercise and education versus saline injections for knee osteoarthritis: a randomised controlled equivalence trial. Ann. Rheum. Dis. 81, 537\u2013543 (2022).","journal-title":"Ann. Rheum. Dis."},{"key":"9415_CR49","unstructured":"RoB 2. A revised Cochrane risk-of-bias tool for randomized trials | Cochrane Bias. https:\/\/methods.cochrane.org\/bias\/resources\/rob-2-revised-cochrane-risk-bias-tool-randomized-trials."},{"key":"9415_CR50","unstructured":"Kappa http:\/\/vassarstats.net\/kappa.html"},{"key":"9415_CR51","unstructured":"RevMan. https:\/\/training.cochrane.org\/online-learning\/core-software\/revman"},{"key":"9415_CR52","unstructured":"Hedge\u2019s g Statistic. https:\/\/www.itl.nist.gov\/div898\/software\/dataplot\/refman2\/auxillar\/hedgeg.htm."},{"key":"9415_CR53","unstructured":"Chapter 10. Analysing data and undertaking meta-analyses. https:\/\/training.cochrane.org\/handbook\/current\/chapter-10."},{"key":"9415_CR54","unstructured":"GRADE approach. https:\/\/training.cochrane.org\/grade-approach."},{"key":"9415_CR55","unstructured":"GRADEpro. https:\/\/www.gradepro.org\/."},{"key":"9415_CR56","doi-asserted-by":"crossref","unstructured":"Ikemoto, T. et al. Open-label placebo trial among Japanese patients with chronic low back pain. Pain Res. Manag. 2020, 1\u20138 (2020).","DOI":"10.1155\/2020\/6636979"},{"key":"9415_CR57","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1097\/j.pain.0000000000001683","volume":"160","author":"J Kleine-Borgmann","year":"2019","unstructured":"Kleine-Borgmann, J., Schmidt, K., Hellmann, A. & Bingel, U. Effects of open-label placebo on pain, functional disability, and spine mobility in patients with chronic back pain: a randomized controlled trial. Pain. 160, 2891\u20132897 (2019).","journal-title":"Pain"},{"key":"9415_CR58","doi-asserted-by":"publisher","first-page":"853497","DOI":"10.3389\/fpsyt.2022.853497","volume":"13","author":"E Olliges","year":"2022","unstructured":"Olliges, E. et al. Open-label placebo administration decreases pain in elderly patients with symptomatic knee osteoarthritis\u2014A randomized controlled trial. Front. Psychiatry. 13, 853497 (2022).","journal-title":"Front. Psychiatry"},{"key":"9415_CR59","first-page":"1211","volume":"15","author":"M Pfingsten","year":"2014","unstructured":"Pfingsten, M., Lueder, S., Luedtke, K., Petzke, F. & Hildebrandt, J. Significance of physical performance tests for patients with low back pain. Pain Med. Malden Mass. 15, 1211\u20131221 (2014).","journal-title":"Pain Med. Malden Mass."},{"key":"9415_CR60","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.3389\/fpsyg.2019.02874","volume":"10","author":"J Pietschnig","year":"2019","unstructured":"Pietschnig, J., Siegel, M., Eder, J. S. N. & Gittler, G. Effect declines are systematic, strong, and ubiquitous: A meta-meta-analysis of the decline effect in intelligence research. Front. Psychol. 10, 2874 (2019).","journal-title":"Front. Psychol."},{"key":"9415_CR61","doi-asserted-by":"crossref","unstructured":"Bernstein, M. H., Magill, M., Beaudoin, F. L., Becker, S. J. & Rich, J. D. Harnessing the placebo effect: a promising method for curbing the opioid crisis? Addiction. 113, 2144\u20132145 (2018).","DOI":"10.1111\/add.14385"},{"key":"9415_CR62","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000490354","volume":"87","author":"AWM Evers","year":"2018","unstructured":"Evers, A. W. M. et al. Implications of placebo and nocebo effects for clinical practice: expert consensus. Psychother. Psychosom. 87, 204\u2013210 (2018).","journal-title":"Psychother. Psychosom."},{"key":"9415_CR63","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1136\/medethics-2019-105893","volume":"47","author":"L Specker Sullivan","year":"2021","unstructured":"Specker Sullivan, L. More than consent for ethical open-label placebo research. J. Med. Ethics. 47, e7\u2013e7 (2021).","journal-title":"J. Med. Ethics"},{"key":"9415_CR64","doi-asserted-by":"publisher","first-page":"700","DOI":"10.31128\/AJGP-05-19-4939","volume":"48","author":"C Blease","year":"2019","unstructured":"Blease, C. The role of placebos in family medicine: implications of evidence and ethics for general practitioners. Aust J. Gen. Pract. 48, 700\u2013705 (2019).","journal-title":"Aust J. Gen. Pract."},{"key":"9415_CR65","doi-asserted-by":"publisher","unstructured":"Hohenschurz-Schmidt, D. et al. Recommendations for the development, implementation, and reporting of control interventions in efficacy and mechanistic trials of physical, psychological, and self-management therapies: the CoPPS statement. BMJ. e072108 https:\/\/doi.org\/10.1136\/bmj-2022-072108 (2023).","DOI":"10.1136\/bmj-2022-072108"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09415-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09415-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09415-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:03:16Z","timestamp":1751673796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09415-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,5]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9415"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-09415-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,5]]},"assertion":[{"value":"26 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24007"}}